GSA Capital Partners’s Nutex Health NUTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$537K Buy
2,535
+737
+41% +$136K 0.03% 1001
2026
Q2
$307K Buy
+1,798
New +$228K 0.02% 1290
2025
Q4
– Sell
-4,729
Closed -$489K – 1957
2025
Q3
$489K Buy
4,729
+1,110
+31% +$109K 0.04% 863
2025
Q2
$451K Buy
+3,619
New +$467K 0.03% 997
2024
Q1
– Sell
-3,382
Closed -$91K – 1860
2023
Q4
$91K Buy
3,382
+1,357
+67% +$42.3K 0.01% 1402
2023
Q3
$62K Buy
+2,025
New +$97.7K 0.01% 1410

Other funds holding NUTX

GSA Capital Partners's NUTX Position: Q3 2026 in Review

GSA Capital Partners increased its Nutex Health (NUTX) stake by 41% in Q3 2026, buying an estimated $136K and bringing the position to 2,535 shares worth $537K. The position accounts for 0.03% of the portfolio, ranked #1001.

GSA Capital Partners first reported a position in NUTX in Q3 2023 and has held it in 6 quarters since. 184 funds tracked by Wall St. Rank hold NUTX as of Q3 2026.

  • GSA Capital Partners held 2,535 shares of Nutex Health worth $537K as of Q3 2026.
  • GSA Capital Partners bought 737 Nutex Health shares in Q3 2026, an estimated $136K.
  • Nutex Health made up 0.03% of GSA Capital Partners's portfolio in Q3 2026, its #1001 holding.
  • GSA Capital Partners first reported a position in Nutex Health in Q3 2023 and has held it in 6 quarters since.
  • 184 funds tracked by Wall St. Rank held Nutex Health as of Q3 2026.

Based on GSA Capital Partners's 13F filing for Q3 2026, filed 16 Nov 2026.